Abstract
Opportunistic fungi of the genus Candida are currently considered as the major causative agents of mycoses, which are characterized by an especially severe course under conditions of acquired immunodeficiency. The main target for the development of new antimycotics is the cytochrome P450 51 (CYP51) of the pathogenic fungus. The widespread distribution of Candida strains resistant to the azole class of CYP51 inhibitors point to the clear need for the screening for CYP51 inhibitors both among non-azole compounds and among clinically used drugs, which would be repositioned as antimycotics. In this study an integrated approach including bioinformatics analysis, computer molecular modeling, and a surface plasmon resonance (SPR) technology was employed to identify potential inhibitors from the non-azole group. Using in silico modeling, the binding sites for acetylsalicylic acid, ibuprofen, chlorpromazine and haloperidol (these compounds, according to the literature, showed antimycotic activity) were predicted in the active site of CYP51 from Candida albicans and Candida glabrata. The Kd values of molecular complexes of acetylsalicylic acid, ibuprofen and haloperidol with CYP51, determined by SPR analysis, ranged from 18 μM to 126 μM. It was also shown that structural derivatives of haloperidol, containing various substituents, could be positioned in the active site Candida albicans CYP51 with possible formation of coordination bonds between the hydroxyl groups of the derivatives and the heme iron atom of CYP51. Thus, the potential lead structures of non-azole compounds have been proposed; they can be used for the design of new CYP51 inhibitors of Candida fungi.
Similar content being viewed by others
REFERENCES
Pappas, P.G., Kauffman, C.A., Andes, D.R., Clancy, C.J., Marr, K.A., Ostrosky-Zeichner, L., Reboli, A.C., Schuster, M.G., Vazquez, J.A., Walsh, T.J., Zaoutis, T.E., and Sobel, J.D., Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., 2016, vol. 62, pp. e1-50. https://doi.org/10.1093/cid/civ933
Warrilow, A.G., Parker, J.E., Kelly, D.E., and Kelly, S.L., Antimicrob. Agents Chemother., 2013, vol. 57, pp. 1352–1360. https://doi.org/10.1128/AAC.02067-12
Wang, F.-J., Zhang, D., Liu, Z.-H., Wu, W.-X., Bai, H.-H., and Dong, H.-Y., Chin. Med. J. (Engl.), 2016, vol. 129, pp. 1161–1165. https://doi.org/10.4103/0366-6999.181964
Masamrekh, R., Kuzikov, A., Veselovsky, A., Toropygin, I., Shkel, T., Strushkevich, N., Gilep, A., Usanov, S., Archakov, A., and Shumyantseva, V., J. Inorg. Biochem., 2018, vol. 186, pp. 24–33. https://doi.org/10.1016/j.jinorgbio.2018.05.010
Afeltra, J. and Verweij, P.E., Eur. J. Clin. Microbiol. Infect. Dis. Off. Publ. Eur. Soc. Clin. Microbiol., 2003, vol. 22, pp. 397–407. https://doi.org/10.1007/s10096-003-0947-x
Stylianou, M., Kulesskiy, E., Lopes, J.P., Granlund, M., Wennerberg, K., and Urban, C.F., Antimicrob. Agents Chemother., 2014, vol. 58, pp. 1055–1062. https://doi.org/10.1128/AAC.01087-13
Lagunin, A., Stepanchikova, A., Filimonov, D., and Poroikov, V., Bioinformatics, 2000, vol. 16, pp. 747–748. https://doi.org/10.1093/bioinformatics/16.8.747
Shkel, T.V., Vasilevskaya, A.V., Gilep, A.A., Usanov, S.A., Chernovetsky, M.A., and Lukyanea’ko, I.G., Dokl. Nat. Akad. Nauk Belarus, 2017, vol. 56, pp. 64–71.
Shkel, T.V., Grabovec, I.P., Gilep, A.A., Varaksa, T.S., Strushkevich, N.V., Dolgopalets, V.I., and Charnou, Y.G., Proc. Natl. Acad. Sci. Belarus Chem. Ser., 2019, vol. 54, pp. 450–454. https://doi.org/10.29235/1561-8331-2018-54-4-450-454
Kim, J.H., Chan, K.L., Cheng, L.W., Tell, L.A., Byrne, B.A., Clothier, K., and Land, K.M., Methods Protoc., 2019, vol. 2, 31. https://doi.org/10.3390/mps2020031
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E., J. Comput. Chem., 2004, vol. 25, pp. 1605–1612. https://doi.org/10.1002/jcc.20084
Grosdidier, A., Zoete, V., and Michielin, O., Nucl. Acids Res., 2011, vol. 39, pp. W270–W277. https://doi.org/10.1093/nar/gkr366
Grosdidier, A., Zoete, V., and Michielin, O., J. Comput. Chem., 2011, vol. 32, pp. 2149–2159. https://doi.org/10.1002/jcc.21797
Zoete, V., Daina, A., Bovigny, C., and Michielin, O., J. Chem. Inf. Model., 2016, vol. 56, pp. 1399–1404. https://doi.org/10.1021/acs.jcim.6b00174
Wang, M.-Y., Wang, F., Hao, G.-F., and Yang, G.-F., J. Agric. Food Chem., 2019, vol. 67, pp. 1823–1830. https://doi.org/10.1021/acs.jafc.8b06596
Backman, T.W.H., Cao, Y., and Girke, T., Nucl. Acids Res., 2011, vol. 39, pp. W486–W491. https://doi.org/10.1093/nar/gkr320
Goddard, T.D., Huang, C.C., Meng, E.C., Pettersen, E.F., Couch, G.S., Morris, J.H., and Ferrin, T.E., Protein Sci. Publ. Protein Soc., 2018, vol. 27, pp. 14–25. https://doi.org/10.1002/pro.3235
Preissner, S., Kroll, K., Dunkel, M., Senger, C., Goldsobel, G., Kuzman, D., Guenther, S., Winnenburg, R., Schroeder, M., and Preissner, R., Nucl. Acids Res., 2010, vol. 38, pp. D237–D243. https://doi.org/10.1093/nar/gkp970
Ji, C., Liu, N., Tu, J., Li, Z., Han, G., Li, J., and Sheng, C., ACS Infect. Dis., 2020, vol. 6, pp. 768–786. https://doi.org/10.1021/acsinfecdis.9b00197
Schenkman, J.B., Remmer, H., and Estabrook, R.W., Mol. Pharmacol., 1967, vol. 3, pp. 113–123.
von Kries, J.P., Warrier, T., and Podust, L.M., Curr. Protoc. Microbiol., 2010, Chapter 17, Unit 17.4. https://doi.org/10.1002/9780471729259.mc1704s16
Shahrokh, K., Orendt, A., Yost, G.S., and Cheatham, T.E., J. Comput. Chem., 2012, vol. 33, pp. 119–133. https://doi.org/10.1002/jcc.21922
Schlichting, I., Berendzen, J., Chu, K., Stock, A.M., Maves, S.A., Benson, D.E., Sweet, R.M., Ringe, D., Petsko, G.A., and Sligar, S.G., Science, 2000, vol. 287, pp. 1615–1622. https://doi.org/10.1126/science.287.5458.1615
Chen, S.-H., Sheng, C.-Q., Xu, X.-H., Jiang, Y.-Y., Zhang, W.-N., and He, C., Biol. Pharm. Bull., 2007, vol. 30, pp. 1246–1253. https://doi.org/10.1248/bpb.30.1246
Siqueira, T.H. and Martínez, L., J. Biomol. Struct. Dyn., 2020, vol. 38, pp. 1659–1669. https://doi.org/10.1080/07391102.2019.1614998
Gervasini, G., Caballero, M.J., Carrillo, J.A., and Benitez, J., ISRN Pharmacol., 2013, vol. 2013, 792456. https://doi.org/10.1155/2013/792456
Tani, N., Rahnasto-Rilla, M., Wittekindt, C., Salminen, K.A., Ritvanen, A., Ollakka, R., Koskiranta, J., Raunio, H., and Juvonen, R.O., Eur. J. Med. Chem., 2012, vol. 47, pp. 270–277. https://doi.org/10.1016/j.ejmech.2011.10.053
Lv, Z., Sheng, C., Zhang, Y., Wang, T., Feng, J., Sun, H., Zhong, H., Zhang, M., Chen, H., and Li, K. Bioorg. Med. Chem. Lett., 2010, vol. 20, pp. 7106–7109. https://doi.org/10.1016/j.bmcl.2010.09.072
Funding
Bioinformatic analysis and computer modeling were done in the framework of the Russian Federation fundamental research program for the long-term period for 2021−2030. SPR studies were supported by the Russian Foundation for Basic Research (RFBR; project grant no. 20-04-00014), using the equipment of “Human Proteome” Core Facility of the Institute of Biomedical Chemistry (funded by the Russian Ministry of Science and Education, Agreement no. 075-15-2019-1502 of September 5, 2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
The authors declare that they have no conflicts of interest. This work does not contain any research using humans and animals as research objects.
SUPPLEMENTARY INFORMATION
Supplementary materials are available in the electronic version of the article on the journal website (http://pbmc.ibmc.msk.ru).
Additional information
Translated by A. Medvedev
Rights and permissions
About this article
Cite this article
Kaluzhskiy, L.A., Ershov, P.V., Yablokov, E.O. et al. Screening of Potential Non-Azole Inhibitors of Lanosterol 14-Alpha Demethylase (CYP51) of the Сandida Fungi. Biochem. Moscow Suppl. Ser. B 15, 215–223 (2021). https://doi.org/10.1134/S1990750821030045
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750821030045